Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?

<div>Serum creatinine to day 30 after transplant in kidney transplant recipients randomized to start rabbit antithymocyte globulin (rATG) intraoperatively (n=27) or postoperatively (approximately 6 hours after reperfusion, n=31) [<a href="/journals/jtrans/2018/4524837/#B41">41</a>]. The total dose of rATG was 3–6 mg/kg in both groups. Maintenance immunosuppression comprised calcineurin inhibitor therapy (started based on renal function), mycophenolate mofetil (MMF), and steroids. DGF, delayed graft function.</div>

Journal of Transplantation

fig1

Figure 1

Figure 1: Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation? 

Figure 1 | Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation? 